Who owns Relmada Therapeutics Inc?
- Ticker: RLMD
- CUSIP Number: 75955j402
Tip: Access positions for across all investors
Analyze quarterly positions in Relmada Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Relmada Therapeutics stock
Who bought or sold Relmada Therapeutics Inc this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Vanguard Group | 1.3M | $5.8M | -4% | Mar 2024 |
|
Acadian Asset Management | 1.2M | $5.5M | 1% | Mar 2024 |
|
Parsons Capital Management | 974k | $4.5M | 2% | Mar 2024 |
|
Opaleye Management | 759k | $3.5M | -13% | Mar 2024 |
|
Palo Alto Investors | 732k | $3.4M | 0% | Mar 2024 |
|
Franklin Resources | 630k | $2.9M | 100% | Mar 2024 |
|
BlackRock | 578k | $2.7M | 1% | Mar 2024 |
|
Millennium Management | 342k | $1.6M | 72% | Mar 2024 |
|
Two Sigma Advisers | 326k | $1.5M | -1% | Mar 2024 |
|
Geode Capital Management | 256k | $1.2M | 7% | Mar 2024 |
|
Two Sigma Investments | 227k | $1.1M | -25% | Mar 2024 |
|
Deutsche Bank Aktiengesellschaft | 225k | $1.0M | 0% | Mar 2024 |
|
Bank of America Corporation | 211k | $979k | 0% | Mar 2024 |
|
Marshall Wace | 208k | $967k | 35% | Mar 2024 |
|
Bridgeway Capital Management | 196k | $910k | 92% | Mar 2024 |
|
Guild Investment Management | 191k | $888k | -10% | Mar 2024 |
|
Group One Trading | 184k | $857k | 15% | Mar 2024 |
|
Jpmorgan Chase & Co | 176k | $818k | 836% | Mar 2024 |
|
Jane Street | 175k | $815k | 1344% | Mar 2024 |
|
Citadel Advisors | 170k | $788k | -65% | Mar 2024 |
|
Rbf Capital | 166k | $770k | -15% | Mar 2024 |
|
Barclays | 146k | $679k | 0% | Mar 2024 |
|
UBS Group | 129k | $601k | 3% | Mar 2024 |
|
Jacobs Levy Equity Management | 126k | $586k | -41% | Mar 2024 |
|
Citigroup | 124k | $576k | 69% | Mar 2024 |
|
Morgan Stanley | 121k | $560k | -2% | Mar 2024 |
|
Goldman Sachs Group | 118k | $550k | 100% | Mar 2024 |
|
GSA Capital Partners | 103k | $480k | -44% | Mar 2024 |
|
We Are One Seven | 100k | $414k | 0% | Dec 2023 |
|
Federated Investors | 100k | $413k | -13% | Dec 2023 |
|
FMR | 84k | $390k | -1% | Mar 2024 |
|
Northern Trust | 81k | $377k | 72% | Mar 2024 |
|
Squarepoint Ops | 79k | $367k | 8% | Mar 2024 |
|
apricus wealth | 79k | $367k | 0% | Mar 2024 |
|
Dimensional Fund Advisors | 74k | $343k | 0% | Mar 2024 |
|
Cantor Fitzgerald, L. P. | 74k | $357k | 100% | Mar 2024 |
|
Qube Research & Technologies | 73k | $339k | 1801% | Mar 2024 |
|
Man Group | 72k | $336k | 100% | Mar 2024 |
|
AdvisorShares Investments | 70k | $326k | -38% | Mar 2024 |
|
Cubist Systematic Strategies | 51k | $238k | 100% | Mar 2024 |
|
Susquehanna International | 50k | $233k | -6% | Mar 2024 |
|
Point72 Asia | 50k | $232k | 100% | Mar 2024 |
|
Simplex Trading | 47k | $217k | -17% | Mar 2024 |
|
Ikarian Capital | 40k | $188k | 0% | Mar 2024 |
|
Sei Investments | 36k | $170k | 0% | Mar 2024 |
|
Meyer Handelman | 33k | $151k | 0% | Mar 2024 |
|
AlTi Global | 32k | $149k | 1% | Mar 2024 |
|
Belvedere Trading | 32k | $147k | 100% | Mar 2024 |
|
Pensionmark Financial Group | 31k | $143k | 100% | Mar 2024 |
|
Wolverine Trading | 30k | $140k | 7% | Mar 2024 |
|
Horizon Kinetics Asset Management | 30k | $124k | 100% | Dec 2023 |
|
American Century Companies | 28k | $128k | 100% | Mar 2024 |
|
Pegasus Asset Management | 27k | $125k | 0% | Mar 2024 |
|
Connor, Clark & Lunn Investment Management | 26k | $123k | -57% | Mar 2024 |
|
Y-Intercept | 24k | $112k | 100% | Mar 2024 |
|
Mariner Wealth Advisors | 24k | $112k | 15% | Mar 2024 |
|
Sargent Investment Group | 22k | $102k | 100% | Mar 2024 |
|
Tortoise Investment Management | 22k | $101k | 0% | Mar 2024 |
|
Spotlight Asset Group | 20k | $93k | 0% | Mar 2024 |
|
PDT Partners | 16k | $76k | 9% | Mar 2024 |
|
Florida State Board of Administration | 15k | $34k | 100% | Mar 2024 |
|
Brevan Howard Capital Management | 15k | $69k | 100% | Mar 2024 |
|
Stratos Wealth Partners | 14k | $66k | -15% | Mar 2024 |
|
Engineers Gate Manager | 14k | $64k | 100% | Mar 2024 |
|
Charles Schwab Investment Management | 13k | $58k | 0% | Mar 2024 |
|
LPL Financial | 13k | $58k | -4% | Mar 2024 |
|
Balyasny Asset Management | 12k | $57k | 100% | Mar 2024 |
|
SG Americas Securities | 11k | $53k | 100% | Mar 2024 |
|
Bedel Financial Consulting | 10k | $47k | 0% | Mar 2024 |
|
Tower Research Capital | 9.8k | $45k | 471% | Mar 2024 |
|
Cutler | 9.0k | $41k | -3% | Mar 2024 |
|
Hexagon Capital Partners | 4.0k | $19k | 0% | Mar 2024 |
|
Brown Brothers Harriman & Co. | 3.0k | $14k | 0% | Mar 2024 |
|
Lindbrook Capital | 2.5k | $12k | 0% | Mar 2024 |
|
Acima Private Wealth | 1.8k | $7.6k | 0% | Dec 2023 |
|
American Capital Advisory | 1.2k | $2.7k | 0% | Mar 2024 |
|
Rhumbline Advisers | 1.2k | $5.5k | 0% | Mar 2024 |
|
ADAR1 Capital Management | 601.00 | $2.8k | -99% | Mar 2024 |
|
GAMMA Investing | 569.00 | $2.6k | 0% | Mar 2024 |
|
Wells Fargo & Company | 543.00 | $2.5k | 1% | Mar 2024 |
|
Tang Capital Management | 382.00 | $1.8k | 100% | Mar 2024 |
|
Fortitude Family Office | 340.00 | $1.6k | 0% | Mar 2024 |
|
Massmutual Trust | 113.00 | $524.998000 | 0% | Mar 2024 |
|
Advisor Group Holdings | 27.00 | $126.000900 | 0% | Mar 2024 |
|
Front Row Advisors | 6.00 | $28.000200 | 0% | Mar 2024 |
|
Blackston Financial Advisory Group | 2.00 | $9.000000 | 100% | Mar 2024 |
|
Who sold out of Relmada Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Mirae Asset Global Investments | Dec 2023 | 270k | $1.1M |
Point72 Asset Management | Dec 2023 | 250k | $1.0M |
Verition Fund Management | Sep 2023 | 34k | $103k |
Springbok Capital Management | Sep 2023 | 16k | $47k |
Bank of New York Mellon | Dec 2023 | 11k | $46k |
D. E. Shaw & Co | Dec 2023 | 11k | $44k |
Royal Bank of Canada | Dec 2023 | 4.2k | $17k |
Savior | Sep 2023 | 3.5k | $11k |
Quantbot Technologies | Sep 2023 | 1.5k | $4.5k |
Russell Investments | Dec 2023 | 53.00 | $219.001300 |